150 related articles for article (PubMed ID: 21062731)
41. Silencing HO-1 sensitizes SKM-1 cells to apoptosis induced by low concentration 5-azacytidine through enhancing p16 demethylation.
Wang P; Ma D; Wang J; Fang Q; Gao R; Wu W; Lu T; Cao L
Int J Oncol; 2015 Mar; 46(3):1317-27. PubMed ID: 25585641
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
43. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy.
Christman JK
Oncogene; 2002 Aug; 21(35):5483-95. PubMed ID: 12154409
[TBL] [Abstract][Full Text] [Related]
44. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
45. Preliminary study on 5-azacytidine anti-myeloma activity in vitro.
Chen GH; Wu DP; Lin FR; Wang Y; Huang HW; Chang HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):602-6. PubMed ID: 19549372
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
Momparler RL; Côté S; Eliopoulos N
Leukemia; 1997 Feb; 11(2):175-80. PubMed ID: 9009076
[TBL] [Abstract][Full Text] [Related]
47. Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer.
Momparler RL; Bouffard DY; Momparler LF; Dionne J; Belanger K; Ayoub J
Anticancer Drugs; 1997 Apr; 8(4):358-68. PubMed ID: 9180389
[TBL] [Abstract][Full Text] [Related]
48. Antitumor effects of deguelin on H460 human lung cancer cells in vitro and in vivo: Roles of apoptotic cell death and H460 tumor xenografts model.
Hsu YC; Chiang JH; Yu CS; Hsia TC; Wu RS; Lien JC; Lai KC; Yu FS; Chung JG
Environ Toxicol; 2017 Jan; 32(1):84-98. PubMed ID: 26592500
[TBL] [Abstract][Full Text] [Related]
49. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
[TBL] [Abstract][Full Text] [Related]
50. Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine.
Yuan BZ; Jefferson AM; Popescu NC; Reynolds SH
Neoplasia; 2004; 6(4):412-9. PubMed ID: 15256063
[TBL] [Abstract][Full Text] [Related]
51. Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.
Romero OA; Verdura S; Torres-Diz M; Gomez A; Moran S; Condom E; Esteller M; Villanueva A; Sanchez-Cespedes M
Oncogene; 2017 Mar; 36(9):1287-1296. PubMed ID: 27593925
[TBL] [Abstract][Full Text] [Related]
52. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line].
Yang J; Ji W; Qu Y; He L; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):64-6. PubMed ID: 21473137
[TBL] [Abstract][Full Text] [Related]
53. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
Zuo S; Chen Y; Xu L; Tang Q; Zou S
J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
[TBL] [Abstract][Full Text] [Related]
54. Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics.
Chekhun VF; Lozovska YV; Naleskina LA; Borikun TV; Burlaka AP; Todor IN; Demash DV; Yalovenko TM; Zadvornyi TV; Pavlova AO; Storchay DM; Lukianova NY
Exp Oncol; 2016 Dec; 38(4):283-287. PubMed ID: 28230826
[TBL] [Abstract][Full Text] [Related]
55. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
Yang B; Yang ZG; Gao B; Shao GG; Li GH
Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
[TBL] [Abstract][Full Text] [Related]
56. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
[TBL] [Abstract][Full Text] [Related]
57. A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma.
Iwata H; Sato H; Suzuki R; Yamada R; Ichinomiya S; Yanagihara M; Okabe H; Sekine Y; Yano T; Ueno K
Int J Oncol; 2011 Jun; 38(6):1653-61. PubMed ID: 21479360
[TBL] [Abstract][Full Text] [Related]
58. GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is down-regulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription.
Chakraborty AK; Sousa Jde F; Chakraborty D; Funasaka Y; Bhattacharya M; Chatterjee A; Pawelek J
Gene; 2006 Jun; 374():166-73. PubMed ID: 16556489
[TBL] [Abstract][Full Text] [Related]
59. Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.
Gollob JA; Sciambi CJ; Peterson BL; Richmond T; Thoreson M; Moran K; Dressman HK; Jelinek J; Issa JP
Clin Cancer Res; 2006 Aug; 12(15):4619-27. PubMed ID: 16899610
[TBL] [Abstract][Full Text] [Related]
60. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
